Aarti Drugs (BOM:524348) Other Operating Expense : ₹6,137 Mil (TTM As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Other Operating Expense?

Aarti Drugs's Other Operating Expense for the three months ended in Mar. 2025 was ₹1,614 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₹6,137 Mil.

Aarti Drugs's quarterly Other Operating Expense increased from Sep. 2024 (₹1,510 Mil) to Dec. 2024 (₹1,573 Mil) and increased from Dec. 2024 (₹1,573 Mil) to Mar. 2025 (₹1,614 Mil).

Aarti Drugs's annual Other Operating Expense increased from Mar. 2023 (₹1,330 Mil) to Mar. 2024 (₹5,140 Mil) and increased from Mar. 2024 (₹5,140 Mil) to Mar. 2025 (₹6,137 Mil).

Aarti Drugs Other Operating Expense Historical Data

The historical data trend for Aarti Drugs's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Other Operating Expense Chart

Aarti Drugs Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Other Operating Expense

Get a 7-Day Free Trial

1,299.59

1,242.72

1,330.26

5,139.78

6,136.50

Aarti Drugs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															1,506.60	1,439.50	1,510.10	1,572.80	1,614.10

Aarti Drugs Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6,137 Mil.

Aarti Drugs Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Other Operating Expense

Traded in Other Exchanges

AARTIDRUGS:India

Address

Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022

Website

https://www.aartidrugs.co.in

Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.

Aarti Drugs Headlines

No Headlines